These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 20100262
1. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Brewer JD, Christenson LJ, Weenig RH, Weaver AL. Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262 [Abstract] [Full Text] [Related]
2. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. J Am Acad Dermatol; 2005 Dec; 53(6):1067-71. PubMed ID: 16310071 [Abstract] [Full Text] [Related]
3. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. McKenna DB, Lee RJ, Prescott RJ, Doherty VR. Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337 [Abstract] [Full Text] [Related]
4. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Fisher SR. Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046 [Abstract] [Full Text] [Related]
5. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Buettner PG, Leiter U, Eigentler TK, Garbe C. Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700 [Abstract] [Full Text] [Related]
6. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia. Velez NF, Karia PS, Vartanov AR, Davids MS, Brown JR, Schmults CD. JAMA Dermatol; 2014 Mar 01; 150(3):280-7. PubMed ID: 24429548 [Abstract] [Full Text] [Related]
7. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated. Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Milligan D, Bentley P, Fegan C. J Clin Oncol; 2005 Mar 01; 23(7):1514-21. PubMed ID: 15735127 [Abstract] [Full Text] [Related]
8. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC. Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365 [Abstract] [Full Text] [Related]
9. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. Arch Dermatol; 2004 Aug 01; 140(8):985-8. PubMed ID: 15313816 [Abstract] [Full Text] [Related]
10. Follow-up schedules after treatment for malignant melanoma. Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF. Br J Surg; 2008 Nov 01; 95(11):1401-7. PubMed ID: 18844268 [Abstract] [Full Text] [Related]
11. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W. Am Surg; 2000 Jun 01; 66(6):527-31; discussion 531-2. PubMed ID: 10888127 [Abstract] [Full Text] [Related]
12. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ. J Am Acad Dermatol; 2015 Jan 01; 72(1):78-84. PubMed ID: 25440434 [Abstract] [Full Text] [Related]
13. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. Brewer JD, Shanafelt TD, Otley CC, Roenigk RK, Cerhan JR, Kay NE, Weaver AL, Call TG. J Clin Oncol; 2012 Mar 10; 30(8):843-9. PubMed ID: 22331952 [Abstract] [Full Text] [Related]
15. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002). Metelitsa AI, Dover DC, Smylie M, de Gara CJ, Lauzon GJ. J Am Acad Dermatol; 2010 Feb 15; 62(2):227-32. PubMed ID: 20018405 [Abstract] [Full Text] [Related]
16. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B. Acta Med Croatica; 2008 Oct 15; 62(4):351-64. PubMed ID: 19205412 [Abstract] [Full Text] [Related]
17. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, Seigler HF. Ann Surg Oncol; 2006 May 15; 13(5):728-39. PubMed ID: 16538415 [Abstract] [Full Text] [Related]
18. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL. Ann Surg Oncol; 2007 May 15; 14(5):1604-11. PubMed ID: 17333418 [Abstract] [Full Text] [Related]
19. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FG, Muzikansky A, Sober AJ, Tanabe KK. Cancer; 2007 Aug 01; 110(3):614-24. PubMed ID: 17577228 [Abstract] [Full Text] [Related]